共 36 条
- [21] Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case reportINVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 791 - 795Honda, Kazunori论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, JapanKadowaki, Shigenori论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, JapanKato, Kyoko论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, JapanHanai, Nobuhiro论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, JapanHasegawa, Yasuhisa论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Head & Neck Surg, Nagoya, Aichi, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, JapanYatabe, Yasushi论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, JapanMuro, Kei论文数: 0 引用数: 0 h-index: 0机构: Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan
- [22] Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case reportInvestigational New Drugs, 2019, 37 : 791 - 795Kazunori Honda论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical OncologyShigenori Kadowaki论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical OncologyKyoko Kato论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical OncologyNobuhiro Hanai论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical OncologyYasuhisa Hasegawa论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical OncologyYasushi Yatabe论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical OncologyKei Muro论文数: 0 引用数: 0 h-index: 0机构: Aichi Cancer Center Hospital,Department of Clinical Oncology
- [23] A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic TumorINTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (05) : 451 - 459Chang, Bin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R ChinaWang, Zhe论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R ChinaRen, Min论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R ChinaYao, Qianlan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R ChinaZhao, Lu论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R ChinaZhou, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, 270 Dong An Rd, Shanghai 20032, Peoples R China Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China
- [24] Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumorGENES CHROMOSOMES & CANCER, 2002, 34 (04): : 354 - 362Cools, J论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumWlodarska, I论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumSomers, R论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumMentens, N论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumPedeutour, F论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumMaes, B论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumDe Wolf-Peeters, C论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumPauwels, P论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumHagemeijer, A论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, BelgiumMarynen, P论文数: 0 引用数: 0 h-index: 0机构: Univ Leuven VIB, Ctr Human Genet, B-3000 Leuven, Belgium
- [25] Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusionFRONTIERS IN ONCOLOGY, 2022, 12He, Wenguang论文数: 0 引用数: 0 h-index: 0机构: Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R China Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R ChinaJi, Xiao论文数: 0 引用数: 0 h-index: 0机构: Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R China Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R ChinaSong, Congcong论文数: 0 引用数: 0 h-index: 0机构: YuceBio Technol Co Ltd, Dept Translat Med, Shenzhen, Peoples R China Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R ChinaSong, Shanshan论文数: 0 引用数: 0 h-index: 0机构: YuceBio Technol Co Ltd, Dept Translat Med, Shenzhen, Peoples R China Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R ChinaLiu, Lixia论文数: 0 引用数: 0 h-index: 0机构: Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R China Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp,Affiliated Canc Hosp, Tradit Chinese Med Dept,Canc Hosp Affiliated,Chine, Taiyuan, Peoples R China
- [26] STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionJournal of Hematology & Oncology, 8Vivek Subbiah论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Caitlin McMahon论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Shreyaskumar Patel论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Ralph Zinner论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Elvio G Silva论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Julia A. Elvin论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Ishwaria M. Subbiah论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Chimela Ohaji论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Dhakshina Moorthy Ganeshan论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Deepa Anand论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Charles F. Levenback论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Jenny Berry论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Tim Brennan论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Juliann Chmielecki论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Zachary R. Chalmers论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)John Mayfield论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Vincent A. Miller论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Philip J. Stephens论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Jeffrey S. Ross论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)Siraj M. Ali论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Division of Cancer Medicine, Department of Investigational Cancer Therapeutic (Phase I Clinical Trials Program)
- [27] STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusionJOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8Subbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAMcMahon, Caitlin论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAPatel, Shreyaskumar论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Sarcoma Med Oncol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAZinner, Ralph论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USASilva, Elvio G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Diagnost Pathol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAElvin, Julia A.论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USASubbiah, Ishwaria M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAOhaji, Chimela论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAGaneshan, Dhakshina Moorthy论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Diagnost Imaging & Radiol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAAnand, Deepa论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Diagnost Imaging & Radiol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USALevenback, Charles F.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Surg, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USABerry, Jenny论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USABrennan, Tim论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAChmielecki, Juliann论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAChalmers, Zachary R.论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAMayfield, John论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAMiller, Vincent A.论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAStephens, Philip J.论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USARoss, Jeffrey S.论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USAAli, Siraj M.论文数: 0 引用数: 0 h-index: 0机构: Fdn Med Inc, Cambridge, MA 02141 USA Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA
- [28] Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature reviewVirchows Archiv, 2023, 482 : 567 - 580Lili Zhang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyLijuan Luan论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyLicheng Shen论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyRuqun Xue论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyJie Huang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyJieakesu Su论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyYufeng Huang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyYifan Xu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyXiang Wang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyYang Shao论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyYuan Ji论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyChen Xu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of PathologyYingyong Hou论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Pathology
- [29] Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature reviewVIRCHOWS ARCHIV, 2023, 482 (03) : 567 - 580Zhang, Lili论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaLuan, Lijuan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaShen, Licheng论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaXue, Ruqun论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaHuang, Jie论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaSu, Jieakesu论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaHuang, Yufeng论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaXu, Yifan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaWang, Xiang论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaShao, Yang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing, Jiangsu, Peoples R China Nanjing Med Univ, Sch Publ Hlth, Nanjing, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaJi, Yuan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaXu, Chen论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaHou, Yingyong论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China
- [30] Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene: Study of Two Typical Cases and Review of LiteratureFRONTIERS IN MEDICINE, 2022, 9Han, Qianqian论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R ChinaHe, Xin论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R ChinaCui, Lijuan论文数: 0 引用数: 0 h-index: 0机构: Suining Cent Hosp, Dept Pathol, Suining, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R ChinaQiu, Yan论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R ChinaLi, Yuli论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R ChinaChen, Huijiao论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R ChinaZhang, Hongying论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China Sichuan Univ, West China Hosp, Dept Pathol, Chengdu, Peoples R China